Terms: = Breast cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Prognosis
8203 results:
1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
2. Evaluating Recurrence Risk in Patients Undergoing breast-conserving Surgery Using E-cadherin Staining as a Biomarker.
Kao CN; Chen CC; Chu WL; Luo CW; Huang WL; Moi SH; Hou MF; Pan MR
In Vivo; 2024; 38(3):1143-1151. PubMed ID: 38688621
[TBL] [Abstract] [Full Text] [Related]
3. [Malignant Adenomyoepithelioma of the breast:Report of One Case and Literature Review].
Zhao Y; Wen WJ; Zhang XD; An FX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):301-306. PubMed ID: 38686730
[TBL] [Abstract] [Full Text] [Related]
4. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of IDH1 gene expression error in breast tumor biopsy in patients with invasive ductal carcinoma.
Rostami B; Kahrizi S; Ghorbani Yekta B; Ghadyani R; Keramatinia A; Hoseini SJ; Karima S; Nikzamir AR; Mansouri N; Chen M; Movafagh A
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):242-247. PubMed ID: 38678597
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
[TBL] [Abstract] [Full Text] [Related]
7. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
[TBL] [Abstract] [Full Text] [Related]
8. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract] [Full Text] [Related]
9. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
[No Abstract] [Full Text] [Related]
10. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.
Xiao CK; Ren Y; Chen Q; Yang Y; Tang L; Xu L; Ren Z
Epigenetics; 2024 Dec; 19(1):2343593. PubMed ID: 38643489
[TBL] [Abstract] [Full Text] [Related]
11. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological Significance of Tumor Budding in breast Carcinoma.
Buch A; Jain K; Rathod H; Gore C
J Nepal Health Res Counc; 2024 Mar; 21(3):417-427. PubMed ID: 38615212
[TBL] [Abstract] [Full Text] [Related]
14. B7-H3 Expression in breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
15. 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 breast cancer Cell Line.
Bezerra P; Motti EF
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611925
[TBL] [Abstract] [Full Text] [Related]
16. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
17. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract] [Full Text] [Related]
18. Insights into breast cancer Knowledge Among Female Adolescents in Delta State, Nigeria: A School-Based Study.
Akpo MO; Akpo EE; Akpo DO
West Afr J Med; 2024 Feb; 41(2):197-201. PubMed ID: 38583066
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
[TBL] [Abstract] [Full Text] [Related]
[Next]
